 | • レポートコード：QYR9ST01382 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のがんワクチン市場について調査・分析し、以下の構成でお届け致します。がんワクチンの種類別には、予防がんワクチン、治療がんワクチンに、用途別には、子宮頸がん、前立腺がん、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別がんワクチン売上データ ・地域別がんワクチン市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別がんワクチン市場規模：予防がんワクチン、治療がんワクチン ・用途別がんワクチン市場規模：子宮頸がん、前立腺がん、その他 ・主要メーカーの企業情報：Glaxosmithkline、Astellas Pharma、Merck、CSL Limited、Sanpower Group、Sanofi Pasteur、Pfizer、Serum Institute of India ・がんワクチンの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes. Factors such as increasing number of people with cancer, rising public awareness of vaccines, presence of promising late-stage pipeline candidates, and vendors’ patient-assistance programs also augment growth in the cancer vaccines market. Dendritic cells are cells taken from a patient’s immune system and treated with chemicals before being injected back into the patient. These cells produce an enhanced immune response against the malignant cells in the body and stimulate the other cells in the immune system to fight the cancerous cells.
Asia-Pacific witnessed the highest growth rate for cancer vaccines in 2016, and is expected to continue this trend throughout the forecast period. This is attributed to large population base, rise in incidence of HPV infection related cancers & other cancer cases, healthcare infrastructural development, and huge market potential. Moreover, the introduction of novel preventive, therapeutic, and adult cancer vaccines in the market alo
The global Cancer Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cancer Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Cancer Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cancer Vaccines in these regions.
This research report categorizes the global Cancer Vaccines market by top players/brands, region, type and end user. This report also studies the global Cancer Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Glaxosmithkline
Astellas Pharma
Merck
CSL Limited
Sanpower Group
Sanofi Pasteur
Pfizer
Serum Institute of India
Market size by Product
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines
Market size by End User
Cervical Cancer
Prostate Cancer
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cancer Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cancer Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cancer Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cancer Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cancer Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cancer Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Cancer Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Cancer Vaccines Market Size Growth Rate by Product
1.4.2 Preventive Cancer Vaccines
1.4.3 Therapeutic Cancer Vaccines
1.5 Market by End User
1.5.1 Global Cancer Vaccines Market Size Growth Rate by End User
1.5.2 Cervical Cancer
1.5.3 Prostate Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Vaccines Market Size
2.1.1 Global Cancer Vaccines Revenue 2014-2025
2.1.2 Global Cancer Vaccines Sales 2014-2025
2.2 Cancer Vaccines Growth Rate by Regions
2.2.1 Global Cancer Vaccines Sales by Regions
2.2.2 Global Cancer Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Cancer Vaccines Sales by Manufacturers
3.1.1 Cancer Vaccines Sales by Manufacturers
3.1.2 Cancer Vaccines Sales Market Share by Manufacturers
3.1.3 Global Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Vaccines Revenue by Manufacturers
3.2.1 Cancer Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Cancer Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Cancer Vaccines Price by Manufacturers
3.4 Cancer Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Cancer Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Cancer Vaccines Sales by Product
4.2 Global Cancer Vaccines Revenue by Product
4.3 Cancer Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Cancer Vaccines Breakdown Data by End User
6 North America
6.1 North America Cancer Vaccines by Countries
6.1.1 North America Cancer Vaccines Sales by Countries
6.1.2 North America Cancer Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Cancer Vaccines by Product
6.3 North America Cancer Vaccines by End User
7 Europe
7.1 Europe Cancer Vaccines by Countries
7.1.1 Europe Cancer Vaccines Sales by Countries
7.1.2 Europe Cancer Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cancer Vaccines by Product
7.3 Europe Cancer Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Cancer Vaccines by Countries
8.1.1 Asia Pacific Cancer Vaccines Sales by Countries
8.1.2 Asia Pacific Cancer Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Cancer Vaccines by Product
8.3 Asia Pacific Cancer Vaccines by End User
9 Central & South America
9.1 Central & South America Cancer Vaccines by Countries
9.1.1 Central & South America Cancer Vaccines Sales by Countries
9.1.2 Central & South America Cancer Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Cancer Vaccines by Product
9.3 Central & South America Cancer Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Cancer Vaccines by Countries
10.1.1 Middle East and Africa Cancer Vaccines Sales by Countries
10.1.2 Middle East and Africa Cancer Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Cancer Vaccines by Product
10.3 Middle East and Africa Cancer Vaccines by End User
11 Company Profiles
11.1 Glaxosmithkline
11.1.1 Glaxosmithkline Company Details
11.1.2 Company Business Overview
11.1.3 Glaxosmithkline Cancer Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Glaxosmithkline Cancer Vaccines Products Offered
11.1.5 Glaxosmithkline Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Company Business Overview
11.2.3 Astellas Pharma Cancer Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Astellas Pharma Cancer Vaccines Products Offered
11.2.5 Astellas Pharma Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck Cancer Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck Cancer Vaccines Products Offered
11.3.5 Merck Recent Development
11.4 CSL Limited
11.4.1 CSL Limited Company Details
11.4.2 Company Business Overview
11.4.3 CSL Limited Cancer Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 CSL Limited Cancer Vaccines Products Offered
11.4.5 CSL Limited Recent Development
11.5 Sanpower Group
11.5.1 Sanpower Group Company Details
11.5.2 Company Business Overview
11.5.3 Sanpower Group Cancer Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sanpower Group Cancer Vaccines Products Offered
11.5.5 Sanpower Group Recent Development
11.6 Sanofi Pasteur
11.6.1 Sanofi Pasteur Company Details
11.6.2 Company Business Overview
11.6.3 Sanofi Pasteur Cancer Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Sanofi Pasteur Cancer Vaccines Products Offered
11.6.5 Sanofi Pasteur Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Company Business Overview
11.7.3 Pfizer Cancer Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Pfizer Cancer Vaccines Products Offered
11.7.5 Pfizer Recent Development
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Details
11.8.2 Company Business Overview
11.8.3 Serum Institute of India Cancer Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Serum Institute of India Cancer Vaccines Products Offered
11.8.5 Serum Institute of India Recent Development
12 Future Forecast
12.1 Cancer Vaccines Market Forecast by Regions
12.1.1 Global Cancer Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Cancer Vaccines Revenue Forecast by Regions 2019-2025
12.2 Cancer Vaccines Market Forecast by Product
12.2.1 Global Cancer Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global Cancer Vaccines Revenue Forecast by Product 2019-2025
12.3 Cancer Vaccines Market Forecast by End User
12.4 North America Cancer Vaccines Forecast
12.5 Europe Cancer Vaccines Forecast
12.6 Asia Pacific Cancer Vaccines Forecast
12.7 Central & South America Cancer Vaccines Forecast
12.8 Middle East and Africa Cancer Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Cancer Vaccines Product Picture
Table Cancer Vaccines Market Segments
Table Key Manufacturers Cancer Vaccines Covered
Table Global Cancer Vaccines Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Cancer Vaccines Sales Market Share by Product 2014-2025
Figure Preventive Cancer Vaccines Product Picture
Table Major Manufacturers of Preventive Cancer Vaccines
Figure Therapeutic Cancer Vaccines Product Picture
Table Major Manufacturers of Therapeutic Cancer Vaccines
Table Global Cancer Vaccines Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Cervical Cancer
Figure Prostate Cancer
Figure Others
Figure Cancer Vaccines Report Years Considered
Figure Global Cancer Vaccines Market Size 2014-2025 (Million US$)
Figure Global Cancer Vaccines Sales 2014-2025 (K MT)
Table Global Cancer Vaccines Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Cancer Vaccines Sales by Regions 2014-2019 (K MT)
Table Global Cancer Vaccines Sales Market Share by Regions 2014-2019
Figure Global Cancer Vaccines Sales Market Share by Regions 2014-2019
Figure 2018 Global Cancer Vaccines Sales Market Share by Regions
Table Global Cancer Vaccines Revenue by Regions 2014-2019 (Million US$)
Table Global Cancer Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Cancer Vaccines Revenue Market Share by Regions 2014-2019
Figure 2018 Global Cancer Vaccines Revenue Market Share by Regions
Table Global Cancer Vaccines Sales by Manufacturers (2014-2019) (K MT)
Table Global Cancer Vaccines Sales Share by Manufacturers (2014-2019)
Figure Global Cancer Vaccines Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Cancer Vaccines Revenue by Manufacturers (2014-2019) (Million USD)
Table Cancer Vaccines Revenue Share by Manufacturers (2014-2019)
Figure Cancer Vaccines Value Share by Manufacturers in 2018
Table Key Manufacturers Cancer Vaccines Price (2014-2019) (USD/MT)
Table Cancer Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Cancer Vaccines Product Type
Table Date of International Manufacturers Enter into Cancer Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Cancer Vaccines Sales by Product (2014-2019) (K MT)
Table Global Cancer Vaccines Sales Share by Product (2014-2019)
Figure Global Cancer Vaccines Sales Market Share by Product (2014-2019)
Figure Global Cancer Vaccines Sales Market Share by Product in 2018
Table Global Cancer Vaccines Revenue by Product (2014-2019) (Million US$)
Table Global Cancer Vaccines Revenue Share by Product (2014-2019)
Figure Global Cancer Vaccines Revenue Market Share by Product (2014-2019)
Figure Global Cancer Vaccines Revenue Market Share by Product in 2018
Table Cancer Vaccines Price by Product 2014-2019 (USD/MT)
Table Global Cancer Vaccines Sales by End User (2014-2019) (K MT)
Table Global Cancer Vaccines Sales Share by End User (2014-2019)
Figure Global Sales Cancer Vaccines Market Share by End User (2014-2019)
Figure Global Sales Cancer Vaccines Market Share by End User in 2018
Figure North America Cancer Vaccines Sales Growth Rate 2014-2019 (K MT)
Figure North America Cancer Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table North America Cancer Vaccines Sales by Countries (2014-2019) (K MT)
Table North America Cancer Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 North America Cancer Vaccines Sales Market Share by Countries
Table North America Cancer Vaccines Revenue by Countries (2014-2019) (Million US$)
Table North America Cancer Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Cancer Vaccines Revenue Market Share by Countries
Figure United States Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure United States Cancer Vaccines Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Canada Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table North America Cancer Vaccines Sales by Product (2014-2019) (K MT)
Table North America Cancer Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 North America Cancer Vaccines Market Share by Product
Table North America Cancer Vaccines Sales by End User (2014-2019) (K MT)
Table North America Cancer Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 North America Cancer Vaccines Market Share by End User
Figure Europe Cancer Vaccines Sales Growth Rate 2014-2019 (K MT)
Figure Europe Cancer Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Cancer Vaccines Sales by Countries (2014-2019) (K MT)
Table Europe Cancer Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Cancer Vaccines Sales Market Share by Countries
Table Europe Cancer Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Europe Cancer Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Cancer Vaccines Revenue Market Share by Countries
Figure Germany Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Germany Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure France Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure France Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure UK Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Italy Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Russia Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Cancer Vaccines Sales by Product (2014-2019) (K MT)
Table Europe Cancer Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Europe Cancer Vaccines Market Share by Product
Table Europe Cancer Vaccines Sales by End User (2014-2019) (K MT)
Table Europe Cancer Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Europe Cancer Vaccines Market Share by End User
Figure Asia Pacific Cancer Vaccines Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Cancer Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Cancer Vaccines Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Cancer Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cancer Vaccines Sales Market Share by Countries
Table Asia Pacific Cancer Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Cancer Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cancer Vaccines Revenue Market Share by Countries
Figure China Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure China Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Japan Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Korea Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure India Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure India Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Australia Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Cancer Vaccines Sales by Product (2014-2019) (K MT)
Table Asia Pacific Cancer Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Cancer Vaccines Market Share by Product
Table Asia Pacific Cancer Vaccines Sales by End User (2014-2019) (K MT)
Table Asia Pacific Cancer Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Cancer Vaccines Market Share by End User
Figure Central & South America Cancer Vaccines Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Cancer Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Cancer Vaccines Sales by Countries (2014-2019) (K MT)
Table Central & South America Cancer Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cancer Vaccines Sales Market Share by Countries
Table Central & South America Cancer Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Cancer Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cancer Vaccines Revenue Market Share by Countries
Figure Brazil Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Cancer Vaccines Sales by Product (2014-2019) (K MT)
Table Central & South America Cancer Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Cancer Vaccines Market Share by Product
Table Central & South America Cancer Vaccines Sales by End User (2014-2019) (K MT)
Table Central & South America Cancer Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Cancer Vaccines Market Share by End User
Figure Middle East and Africa Cancer Vaccines Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Cancer Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Cancer Vaccines Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Cancer Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cancer Vaccines Sales Market Share by Countries
Table Middle East and Africa Cancer Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Cancer Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cancer Vaccines Revenue Market Share by Countries
Figure GCC Countries Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Cancer Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Cancer Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Cancer Vaccines Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Cancer Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Cancer Vaccines Market Share by Product
Table Middle East and Africa Cancer Vaccines Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Cancer Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Cancer Vaccines Market Share by End User
Table Glaxosmithkline Company Details
Table Glaxosmithkline Cancer Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Glaxosmithkline Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Cancer Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Astellas Pharma Recent Development
Table Merck Company Details
Table Merck Cancer Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Merck Recent Development
Table CSL Limited Company Details
Table CSL Limited Cancer Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table CSL Limited Recent Development
Table Sanpower Group Company Details
Table Sanpower Group Cancer Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Sanpower Group Recent Development
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Cancer Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Sanofi Pasteur Recent Development
Table Pfizer Company Details
Table Pfizer Cancer Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Serum Institute of India Company Details
Table Serum Institute of India Cancer Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Serum Institute of India Recent Development
Table Global Cancer Vaccines Sales Forecast by Regions 2019-2025 (K MT)
Table Global Cancer Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Global Cancer Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Cancer Vaccines Revenue Market Share Forecast by Regions 2019-2025
Table Global Cancer Vaccines Sales Forecast by Product 2019-2025 (K MT)
Table Global Cancer Vaccines Sales Market Share Forecast by Product 2019-2025
Table Global Cancer Vaccines Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Cancer Vaccines Revenue Market Share Forecast by Product 2019-2025
Table Global Cancer Vaccines Sales Forecast by End User 2019-2025 (K MT)
Table Global Cancer Vaccines Sales Market Share Forecast by End User 2019-2025
Figure North America Cancer Vaccines Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Cancer Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Cancer Vaccines Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Cancer Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Cancer Vaccines Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Cancer Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Cancer Vaccines Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Cancer Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Cancer Vaccines Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Cancer Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Cancer Vaccines Value Chain
Table Cancer Vaccines Customers List
Table Cancer Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
がんワクチン薬パイプラインの世界市場：市場規模・現状・予測 Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity.Germany, the U.S. and Japan represent the largest markets for cancer vaccine manufacturers. In 2018, the global Cancer Vaccines Drug Pipeline market size was xx mil…- がん免疫療法の世界市場：市場規模・現状・予測 Cancer immunotherapy is a type of cancer treatment that boosts the human bodys natural immune system to fight against the cancer cells. This therapy is provided to cancer patients to stop the spread of cancer, to slow down the growth of cancer cells, and to improve the natural immunity for destroyin…
- ホルモン不応性前立腺癌(HRPCA)の世界市場：インサイト・予測 Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 前立腺癌の世界市場：市場規模・現状・予測 Prostate cancer is cancer that occurs in the prostate.In 2018, the global Prostate Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Prostate Cancer status, future forecast, grow…
- 世界のRNAワクチン市場：専門的調査 RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which …